Michael Ryskin
Stock Analyst at Bank of America Securities
(3.85)
# 1,936
Out of 4,609 analysts
704
Total ratings
55.3%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintained: Buy | n/a | $17.83 | - | 23 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | n/a | $19.62 | - | 9 | Aug 6, 2026 | |
| BRKR Bruker | Maintained: Buy | n/a | $51.29 | - | 26 | Aug 5, 2026 | |
| ILMN Illumina | Maintained: Sell | $140 | $189.55 | -26.14% | 48 | Aug 5, 2026 | |
| STVN Stevanato Group | Maintained: Buy | n/a | $20.10 | - | 14 | Aug 5, 2026 | |
| WAT Waters | Maintained: Hold | $400 → $415 | $396.00 | +4.80% | 21 | Aug 4, 2026 | |
| DHR Danaher | Maintained: Buy | $230 | $198.41 | +15.92% | 41 | Aug 3, 2026 | |
| MYGN Myriad Genetics | Reiterated: Sell | $4 → $3.2 | $3.08 | +3.90% | 11 | Aug 3, 2026 | |
| TEM Tempus AI | Reiterated: Hold | $64 → $52 | $46.06 | +12.90% | 18 | Aug 3, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | n/a | $1,416.96 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $157.81 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $171.18 | - | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $160.50 | -0.31% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $315.23 | +14.20% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $17.83 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $76.35 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $230.77 | +21.33% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $35.70 | - | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $265 | $237.03 | +11.80% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $347.89 | +17.85% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $630 → $650 | $575.98 | +12.85% | 30 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.4 | $1.95 | +23.39% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $16 | $15.54 | +2.96% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $660 | $587.73 | +12.30% | 32 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $259.16 | - | 19 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $32 | $24.22 | +32.12% | 35 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $155 | $140.70 | +10.16% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $113.26 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $45.18 | - | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $41.54 | +17.96% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $27 | $28.20 | -4.26% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $13.17 | -16.48% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $6.20 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $8.06 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $8.46 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $8.28 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.13 | n/a | 2 | Apr 18, 2022 |
Schrödinger
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $17.83
Upside: -
Caris Life Sciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $19.62
Upside: -
Bruker
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $51.29
Upside: -
Illumina
Aug 5, 2026
Maintained: Sell
Price Target: $140
Current: $189.55
Upside: -26.14%
Stevanato Group
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $20.10
Upside: -
Waters
Aug 4, 2026
Maintained: Hold
Price Target: $400 → $415
Current: $396.00
Upside: +4.80%
Danaher
Aug 3, 2026
Maintained: Buy
Price Target: $230
Current: $198.41
Upside: +15.92%
Myriad Genetics
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $3.08
Upside: +3.90%
Tempus AI
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $46.06
Upside: +12.90%
Mettler-Toledo International
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $1,416.96
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $157.81
Upside: -
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $171.18
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $160.50
Upside: -0.31%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $315.23
Upside: +14.20%
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $17.83
Upside: -
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $76.35
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $230.77
Upside: +21.33%
Jul 28, 2026
Maintained: Sell
Price Target: n/a
Current: $35.70
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $245 → $265
Current: $237.03
Upside: +11.80%
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $347.89
Upside: +17.85%
Jul 23, 2026
Maintained: Buy
Price Target: $630 → $650
Current: $575.98
Upside: +12.85%
Jul 15, 2026
Maintained: Sell
Price Target: $2.4
Current: $1.95
Upside: +23.39%
Jul 13, 2026
Maintained: Hold
Price Target: $11 → $16
Current: $15.54
Upside: +2.96%
Jul 7, 2026
Maintained: Hold
Price Target: $660
Current: $587.73
Upside: +12.30%
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $259.16
Upside: -
Jun 5, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $24.22
Upside: +32.12%
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $140.70
Upside: +10.16%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $113.26
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $45.18
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $41.54
Upside: +17.96%
May 12, 2026
Initiated Coverage: Hold
Price Target: $27
Current: $28.20
Upside: -4.26%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $13.17
Upside: -16.48%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $6.20
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $8.06
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $8.46
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $8.28
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.13
Upside: n/a